Philip J Rosenfeld. Show Affiliations »
Abstract
Mesh： See more » Angiogenesis Inhibitors/bloodAngiogenesis Inhibitors/therapeutic useAnimalsAntibodies, Monoclonal/bloodAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAptamers, Nucleotide/bloodAptamers, Nucleotide/therapeutic useBevacizumabHumansMacular Degeneration/drug therapyRabbitsRanibizumabReference Values
Substances： See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAptamers, NucleotidepegaptanibBevacizumabRanibizumab
Year: 2007 PMID： 17964340 DOI： 10.1016/S0140-6736(07)61624-9
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321